Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1871
https://www.valueinhealthjournal.com/article/S1098-3015(16)33237-5/fulltext
Section Title : Disease-Specific Studies
Section Order : 1768
First Page : A672
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33237-5&doi=10.1016/j.jval.2016.09.1871
HEOR Topics :
Tags :
Regions :